OUR COMMITMENT TO ADVANCING THERAPIES FOR CNS DISORDERS IS REFLECTED IN THE BREADTH OF OUR PIPELINE
Today with over 1 billion people affected by neurological disorders, there is a significant unmet need to discover and develop new medicines for patients with central nervous system (CNS) disorders. In our attempt to meet this urgent need, Upsher-Smith will commit significant resources to develop novel drugs and innovative new treatments for patients. Our lead compounds are focused on epilepsy but we will investigate potential treatments for Parkinson’s disease, cognition, neuropathic pain, neuroinflammation, and obesity.
Epilepsy Learn more »
Epilepsy is a chronic neurological disorder characterized by a tendency for patients to have recurrent seizures. A seizure occurs as a result of a sudden burst of excess electrical activity in the brain, causing a temporary disruption in the communication between brain cells. This disruption may result in severely abnormal brain function and consequent physical manifestations.
According to the Centers for Disease Control and Prevention (CDC), epilepsy affects about 2.3 million adults and 467,711 children 0-17 years of age in the United States.1 It can be caused by many different conditions in the brain, resulting in recurrent seizures. In fact, about 150,000 new cases of epilepsy will be diagnosed in the United States each year.1
To address this growing need, Upsher-Smith has begun a focused effort to develop a pipeline of medications to help those who suffer from this condition.
- Centers for Disease Control and Prevention. Epilepsy fast facts. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/epilepsy/basics/fast_facts.htm. Accessed December 2, 2013.
Leadership Learn more »
At Upsher-Smith, we are proud of our heritage of providing the right products to make people’s lives better. We began in 1919 as a US company in Minnesota and we remain a US company with our manufacturing headquarters located in Plymouth, Minnesota. On a local level, we have a strong history of impactful work and charitable contributions. Our employees participate in walkathons, fundraisers, and internal education programs to create a better awareness of medical conditions affecting our friends and neighbors. We view these activities as a privilege rather than a service.
Sharing knowledge is vital for discovering new treatments and improved outcomes for patients. We believe that improving patient and caregiver education, and increasing disease awareness, are also vital for understanding CNS disorders and the economic burden they pose. Upsher-Smith is diligently working to provide forums where healthcare professionals, patients, and caregivers can share their experiences, expertise, and new findings with the broader community. It is through continuous improvement in disease state education and patient support programs, as well as advancements in both drug development and treatment paradigms, that we are able to team with physicians to improve patient outcomes.
During a time when the US government is undergoing a deeply transformative process, which has heavy implications for the healthcare sector, Upsher-Smith is committed to being an advocate for those suffering from CNS disorders. We are also partnering with other organizations to eliminate the stigma associated with CNS disorders by improving education for our patients, caregivers, and community.